VOOZH about

URL: https://www.nature.com/articles/aps201354?error=cookies_not_supported&code=5adbd0ea-af00-4ecd-9459-04c5b66be82d

⇱ Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection | Acta Pharmacologica Sinica

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Abstract

Aim:

To investigate the effects of arbidol hydrochloride (ARB), a widely used antiviral agent, on the inflammation induced by influenza virus.

Methods:

MDCK cells were infected with seasonal influenza A/FM/1/47 (H1N1) or pandemic influenza A/Hubei/71/2009 (H1N1). In vitro cytotoxicity and antiviral activity of ARB was determined using MTT assay. BALB/c mice were infected with A/FM/1/47 (H1N1). Four hours later the mice were administered ARB (45, 90, and 180 mg·kg−1·d−1) or the neuraminidase inhibitor oseltamivir (22.5 mg·kg−1·d−1) via oral gavage once a day for 5 d. Body-weight, median survival time, viral titer, and lung index of the mice were measured. The levels of inflammatory cytokines were examined using real-time RT-PCR and ELISA.

Results:

Both H1N1 stains were equally sensitive to ARB as tested in vitro. In the infected mice, ARB (90 and 180 mg·kg−1·d−1) significantly decreased the mortality, alleviated virus-induced lung lesions and viral titers. Furthermore, ARB suppressed the levels of IL-1β, IL-6, IL-12, and TNF-α, and elevated the level of IL-10 in the bronchoalveolar lavage fluids and lung tissues. However, ARB did not significantly affect the levels of IFN-α and IFN-γ, but reduced the level of IFN-β1 in lung tissues at 5 dpi. In peritoneal macrophages challenged with A/FM/1/47 (H1N1) or poly I:C, ARB (20 μmol/L) suppressed the levels of IL-1β, IL-6, IL-12, and TNF-α, and elevated the level of IL-10. Oseltamivir produced comparable alleviation of virus-induced lung lesions with more reduction in the viral titers, but less effective modulation of the inflammatory cytokines.

Conclusion:

ARB efficiently inhibits both H1N1 stains and diminishes both viral replication and acute inflammation through modulating the expression of inflammatory cytokines.

Similar content being viewed by others

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

or

👁 Image
Continue with Google
👁 Image
Continue with ORCiD

References

  1. Clem A, Galwankar S . Seasonal influenza: waiting for the next pandemic. J Glob Infect Dis 2009; 1: 51–6.

    Article  Google Scholar 

  2. Fields BN, Knipe DM, Howley PM . Fields virology. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007.

  3. La Gruta NL, Kedzierska K, Stambas J, Doherty PC . A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007; 85: 85–92.

    Article  Google Scholar 

  4. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310: 77–80.

    Article  CAS  Google Scholar 

  5. CDC. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 433–5.

  6. Cheng PK, Leung TW, Ho EC, Leung PC, Ng AY, Lai MY, et al. Oseltamivir- and amantadine-resistant influenza viruses A (H1N1). Emerg Infect Dis 2009; 15: 966–8.

    Article  Google Scholar 

  7. Zaraket H, Saito R, Suzuki Y, Baranovich T, Dapat C, Caperig-Dapat I, et al. Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses. J Clin Microbiol 2010; 48: 1085–92.

    Article  CAS  Google Scholar 

  8. Ludwig S . Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J Antimicrob Chemother 2009; 64: 1–4.

    Article  CAS  Google Scholar 

  9. Josset L, Textoris J, Loriod B, Ferraris O, Moules V, Lina B, et al. Gene expression signature-based screening identifies new broadly effective influenza A antivirals. PLoS One 2010; 5: e13169.

    Article  Google Scholar 

  10. Leneva IA, Fediakina IT, Gus'kova TA, Glushkov RG . Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A. Ter Arkh 2005; 77: 84–8.

    CAS  PubMed  Google Scholar 

  11. Leneva IA, Shuster AM . Antiviral etiotropic chemicals: efficacy against influenza A viruses a subtype H5N1. Vopr Virusol 2006; 51: 4–7.

    CAS  PubMed  Google Scholar 

  12. Shi L, Xiong H, He J, Deng H, Li Q, Zhong Q, et al. Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo. Arch Virol 2007; 152: 1447–55.

    Article  CAS  Google Scholar 

  13. Leneva IA, Sokolova MV, Fediakina IT, Khristova ML, Fadeeva NI, Gus'kova TA . Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay. Vopr Virusol 2002; 47: 42–5.

    CAS  PubMed  Google Scholar 

  14. Zhong Q, Yang Z, Liu Y, Deng H, Xiao H, Shi L, et al. Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo. Arch Virol 2009; 154: 601–7.

    Article  CAS  Google Scholar 

  15. Deng HY, Luo F, Shi LQ, Zhong Q, Liu YJ, Yang ZQ . Efficacy of arbidol on lethal hantaan virus infections in suckling mice and in vitro. Acta Pharmacol Sin 2009; 30: 1015–24.

    Article  CAS  Google Scholar 

  16. Chai H, Zhao Y, Zhao C, Gong P . Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates. Bioorg Med Chem 2006; 14: 911–7.

    Article  CAS  Google Scholar 

  17. Boriskin YS, Leneva IA, Pecheur EI, Polyak SJ . Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem 2008; 15: 997–1005.

    Article  CAS  Google Scholar 

  18. Brooks MJ, Sasadeusz JJ, Tannock GA . Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline? Curr Opin Pulm Med 2004; 10: 197–203.

    Article  CAS  Google Scholar 

  19. Teissier E, Zandomeneghi G, Loquet A, Lavillette D, Lavergne JP, Montserret R, et al. Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol. PLoS One 2011; 6: e15874.

    Article  CAS  Google Scholar 

  20. Leneva IA, Russell RJ, Boriskin YS, Hay AJ . Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol. Antivir Res 2009; 81: 132–40.

    Article  CAS  Google Scholar 

  21. Brooks MJ, Burtseva EI, Ellery PJ, Marsh GA, Lew AM, Slepushkin AN, et al. Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions. J Med Virol 2012; 84: 170–81.

    Article  CAS  Google Scholar 

  22. Glushkov RG, Gus'kova TA, Krylova L, Nikolaeva IS . Mechanisms of arbidole's immunomodulating action. Vestn Ross Akad Med Nauk 1999; (3): 36–40.

    Google Scholar 

  23. Silin DS, Lyubomska OV, Ershov FI, Frolov VM, Kutsyna GA . Synthetic and natural immunomodulators acting as interferon inducers. Curr Pharm Design 2009; 15: 1238–47.

    Article  CAS  Google Scholar 

  24. Boriskin YS, Pecheur EI, Polyak SJ . Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection. Virol J 2006; 3: 56.

    Article  Google Scholar 

  25. Zhao JR, Li YD, Pan LM, Zhu N, Ni HX, Xu GZ, et al. Genetic characteristics of 2009 pandemic H1N1 influenza A viruses isolated from Mainland China. Virol Sin 2011; 26: 418–27.

    Article  Google Scholar 

  26. Xu L, Bao L, Li F, Lv Q, Ma Y, Zhou J, et al. Adaption of seasonal H1N1 influenza virus in mice. PLoS One 2011; 6: e28901.

    Article  CAS  Google Scholar 

  27. Drusano GL, Preston SL, Smee D, Bush K, Bailey K, Sidwell RW . Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing. Antimicrob Agents Chemother 2001; 45: 2115–8.

    Article  CAS  Google Scholar 

  28. Triana-Baltzer GB, Gubareva LV, Nicholls JM, Pearce MB, Mishin VP, Belser JA, et al. Novel pandemic influenza A (H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One 2009; 4: e7788.

    Article  Google Scholar 

  29. Yatmaz S, Seow HJ, Gualano RC, Wong ZX, Stambas J, Selemidis S, et al. Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation. Am J Respir Cell Mol Biol 2013; 48: 17–26.

    Article  CAS  Google Scholar 

  30. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010; 120: 2395–405.

    Article  CAS  Google Scholar 

  31. Zhang X, Goncalves R, Mosser DM . The isolation and characterization of murine macrophages. Curr Protoc Immunol 2008; Chapter 14: Unit 14.1.

    PubMed  Google Scholar 

  32. Prichard MN, Turk SR, Coleman LA, Engelhardt SL, Shipman C Jr, Drach JC . A microtiter virus yield reduction assay for the evaluation of antiviral compounds against human cytomegalovirus and herpes simplex virus. J Virol Methods 1990; 28: 101–6.

    Article  CAS  Google Scholar 

  33. Leneva IA, Fadeeva NI, Fedyakina IT, Gus'kova TA, Khristova NL, Sokolova MV, et al. Use of enzyme immunoassay to identify virus-specific antigens in studying a new anti-influenza preparation, arbidol. Pharm Chem J 1994; 28: 506–605.

    Article  Google Scholar 

  34. Glushkov RG, Fadeeva NI, Leneva IA, Gerasina SF, Budanova LI, Sokolova ND, et al. Molecular biological characteristics of the action of arbidol — A new antiviral drug. Pharm Chem J 1992; 26: 106–15.

    Google Scholar 

  35. Leneva IA, Fediakina IT, Eropkin M, Gudova NV, Romanovskaia AA, Danilenko DM, et al. Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models. Vopr Virusol 2010; 55: 19–27.

    CAS  PubMed  Google Scholar 

  36. Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, et al. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol 2007; 9: 1683–94.

    Article  CAS  Google Scholar 

  37. Sladkova T, Kostolansky F . The role of cytokines in the immune response to influenza A virus infection. Acta Virol 2006; 50: 151–62.

    CAS  PubMed  Google Scholar 

  38. Tate MD, Pickett DL, van Rooijen N, Brooks AG, Reading PC . Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 2010; 84: 7569–80.

    Article  CAS  Google Scholar 

  39. Pommerenke C, Wilk E, Srivastava B, Schulze A, Novoselova N, Geffers R, et al. Global transcriptome analysis in influenza-infected mouse lungs reveals the kinetics of innate and adaptive host immune responses. PLoS One 2012; 7: e41169.

    Article  CAS  Google Scholar 

  40. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3: 196–200.

    Article  CAS  Google Scholar 

  41. Murphy EA, Davis JM, McClellan JL, Carmichael MD, Rooijen NV, Gangemi JD . Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophages. J Interferon Cytokine Res 2011; 31: 501–8.

    Article  CAS  Google Scholar 

  42. Osterlund P, Pirhonen J, Ikonen N, Ronkko E, Strengell M, Makela SM, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010; 84: 1414–22.

    Article  CAS  Google Scholar 

  43. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S . Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12: 171–80.

    Article  CAS  Google Scholar 

  44. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, et al. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 2004; 85: 2347–56.

    Article  CAS  Google Scholar 

  45. Matikainen S, Pirhonen J, Miettinen M, Lehtonen A, Govenius-Vintola C, Sareneva T, et al. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 2000; 276: 138–47.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Mega Project on Major Drug Development (2009ZX09301-014-1), the National Natural Science Foundation of China (N 30873104 and 81000734) and the Fundamental Research Funds for the Central Universities (4101045).

We thank Prof Tian-xian LI for the viruses. We gratefully acknowledge all individuals within the ABSL-3 team for their kindness and their technical help.

Author information

Author notes

  1. Qiang Liu and Hai-rong Xiong: These authors contributed equally to this work.

Authors and Affiliations

  1. State Key Laboratory of Virology/Institute of Medical Virology/Research Center of Food and Drug Evaluation, School of Medicine, Wuhan University, Wuhan, 430071, China

    Qiang Liu, Hai-rong Xiong, Li Lu, Yuan-yuan Liu, Fan Luo, Wei Hou & Zhan-qiu Yang

Corresponding author

Correspondence to Zhan-qiu Yang.

About this article

Cite this article

Liu, Q., Xiong, Hr., Lu, L. et al. Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection. Acta Pharmacol Sin 34, 1075–1083 (2013). https://doi.org/10.1038/aps.2013.54

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/aps.2013.54

Keywords

This article is cited by

Search

Advanced search

Quick links